The aim of this study was to determine if transdermal penetration of levosi
mendan, a novel positive inotropic drug, could be enhanced and controlled b
y formulation modifications. Penetration of levosimendan across human epide
rmis in vitro was determined using abdominal excised skin and diffusion cel
ls. Predicted steady-state plasma concentrations of levosimendan were estim
ated using permeabilities and pharmacokinetic parameters of levosimendan. F
or penetration enhancement we used different pH values, co-solvents, cyclod
extrins, surfactants, penetration enhancers, liposomes, and iontophoresis.
Sodium lauryl sulfate, ethanol, oleic acid, and soya phosphatidylcholine or
their combinations clearly increased levosimendan permeation across the sk
in in vitro. Iontophoresis was also an efficient method to increase transde
rmal permeation of levosimendan. A hydrophilic co-solvent/penetration enhan
cer is needed to achieve better permeability of levosimendan across the ski
n. In conclusion, transdermal delivery of levosimendan can be significantly
increased by formulation modification. Based on kinetic calculations, ther
apeutic plasma concentrations may be achievable transdermally, (C) 2000 Els
evier Science B.V. All rights reserved.